Amneal Pharmaceuticals
Earnings Date & Report
Last updated:
Amneal Pharmaceuticals’s last earnings date was on 5 Nov 2024.
Amneal Pharmaceuticals stock Earnings report, Estimates & History
| 2020-02-26 | 0.05 | 0.08 |
|---|---|---|
| 2020-05-11 | 0.08 | 0.2 |
| 2020-08-06 | 0.1 | 0.13 |
| 2020-11-06 | 0.13 | 0.16 |
| 2021-02-26 | 0.13 | 0.14 |
| 2021-05-07 | 0.18 | 0.2 |
| 2021-08-09 | 0.18 | 0.25 |
| 2021-11-03 | 0.2 | 0.21 |
| 2022-03-02 | 0.19 | 0.18 |
| 2022-05-04 | 0.12 | 0.12 |
| 2022-08-05 | 0.2 | 0.19 |
| 2022-11-04 | 0.18 | 0.14 |
| 2023-03-02 | 0.21 | 0.23 |
| 2023-05-05 | 0.09 | 0.12 |
| 2023-08-04 | 0.1 | 0.19 |
| 2023-11-07 | 0.12 | 0.19 |
| 2024-03-01 | 0.07 | 0.14 |
| 2024-05-03 | 0.09 | 0.14 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Amneal Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 5 Nov 2024 | N/A | N/A | N/A | N/A | N/A | |
| 9 Aug 2024 | N/A | $0.14 | N/A | N/A | N/A | |
| 3 May 2024 | Beat | $0.09 | $0.14 | N/A | 659.19M | Earnings Call Transcript |
| 1 Mar 2024 | Beat | $0.07 | $0.14 | 663.56M | 616.98M | Earnings Call Transcript |
| 7 Nov 2023 | Beat | $0.12 | $0.19 | 634.23M | 620.04M | Earnings Call Transcript |
| 4 Aug 2023 | Beat | $0.1 | $0.19 | 565.41M | 599.04M | Earnings Call Transcript |
| 5 May 2023 | Beat | $0.09 | $0.12 | 537.31M | 557.54M | Earnings Call Transcript |
| 2 Mar 2023 | Beat | $0.21 | $0.23 | 562.15M | 609.75M | Earnings Call Transcript |
| 4 Nov 2022 | Missed | $0.18 | $0.14 | N/A | 545.55M | Earnings Call Transcript |
| 5 Aug 2022 | Missed | $0.2 | $0.19 | N/A | 559.35M | Earnings Call Transcript |
| 4 May 2022 | Matched | $0.12 | $0.12 | 535.91M | 497.63M | Earnings Call Transcript |
| 2 Mar 2022 | Missed | $0.19 | $0.18 | 502.29M | 536.89M | Earnings Call Transcript |
| 3 Nov 2021 | Beat | $0.2 | $0.21 | 544.49M | 528.59M | Earnings Call Transcript |
| 9 Aug 2021 | Beat | $0.18 | $0.25 | 535.07M | 535.07M | Earnings Call Transcript |
| 7 May 2021 | Beat | $0.18 | $0.2 | 438.31M | 493.10M | Earnings Call Transcript |
| 26 Feb 2021 | Beat | $0.13 | $0.14 | 510.03M | 510.03M | Earnings Call Transcript |
| 6 Nov 2020 | Beat | $0.13 | $0.16 | 519.29M | 519.29M | Earnings Call Transcript |
| 6 Aug 2020 | Beat | $0.1 | $0.13 | 357.43M | 464.66M | |
| 11 May 2020 | Beat | $0.08 | $0.2 | 411.28M | 498.53M | Earnings Call Transcript |
| 26 Feb 2020 | Beat | $0.05 | $0.08 | 248.33M | 397.32M | Earnings Call Transcript |
Amneal Pharmaceuticals Earnings report FAQs
When is Amneal Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Amneal Pharmaceuticals's earnings date was on 7 Nov 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.